Tag Search Results: pharmacodiagnostics

Diagnostic tests employed to identify cancer patients eligible for
treatment with targeted therapies, also known af companion diagnostics.

Products (no match found)

 

Service & Support (no match found)

 

Knowledge Center (16)

# Title Description
1Connection 9Page 1. In this issue ER/PR Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry Craig Allred Image Analysis ...
2Connection 9Page 1. In this issue ER/PR Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry Craig Allred Image Analysis ...
3Connection 9Page 1. In this issue ER/PR Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry Craig Allred Image Analysis ...
4Development of pharmacoDiagnostic Tests for Molecular Targeted ... Page 1. Development of pharmacoDiagnostic TM Tests for Molecular Targeted Therapies Yoichi Tani, Yutaka Hatanaka and Kaoru Hashizume Dako Co. Ltd., Kyoto, Japan ...
5Article Pharmacodiagnostic in Breast CancerPage 1. Connection 2008 | 39 T he molecular pathology of cancer is increasingly complex. Novel therapies and greater understanding ...

Show all (16)

About Dako (no match found)

 

Country selection

Your Dako Account indicates that you are based in , you will be transfered to the web site for

Basket emptied

Your basket was emptied because of the country change.

Country selection

United States of America appears to be your location. To view country specific information on the Dako web site, please accept or change country below.



Get in Touch with Dako in Spain

  • Pathology Products
    Dako Diagnósticos, S.A.

    clientes@dako.com
    +34 93 499 05 06
    +34 93 499 02 08

    Edificio Euro 3
    C/ Federico Mompou, 5 Bajos A 1a
    E-08960 Sant Just Desvern (Barcelona)

  • Flow Cytometry Products and Specific Proteins
    Palex Medical SA

    palex@palex.es
    +34 - 93 400 65 00
    +34 - 93 400 65 01

    Francesc Viñas, 5
    08174 Sant Cugat del Vallés
    Barcelona

Detailed contact information

Submit an Inquiry

How would you like us to follow up?